Rubicon Research
add_icon

Rubicon Research

640.00
+2.55
(0.40%)
Market Cap
₹10,544.02 Cr
PE Ratio
85.19
Volume
38,609.00
Day High - Low
₹643.20 - ₹635.00
52W High-Low
₹754.80 - ₹570.75
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
10,544.02 Cr
EPS
8.82
PB Ratio
10.96
Book Value
63.41
EBITDA
255.94
Dividend Yield
0.00 %
Industry
Healthcare
ROE Growth %
-
Debt to Equity
1.11
Analyst Rating and Forecast
- By Refinitiv from1 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %
Forecast For
Actual

Company News

View All News
Caret
positive
Rubicon Research guides for Q2FY26 revenue of ₹4,120 million (39% YoY growth) and EBITDA of ₹943 million (53% YoY growth), with plans to operationalize its Pithampur plant by mid-CY26. The company targets increased specialty products share, global NDAs, and double-digit margin expansion as outsourcing normalizes by FY27.
negative
Rubicon Research Limited reported two cases of insider trading violations under SEBI regulations. In the first case, Vice President Mr. Amol Shamrao Masal sold 30 shares worth Rs. 18,090 on October 28, 2025. The shares were acquired through IPO, resulting in a contra trade executed during the trading window closure period. In the second case, Ms. Romola Pinto (Head HR Admin) and her immediate relative Mr. Vikram N Pinto acquired 20 shares worth Rs. 12,446.20 on October 16, 2025, during the trading window closure period. Both trades were below Rs. 10 lakhs threshold. The company issued warning letters to both designated persons, citing that the trades were inadvertent with insignificant amounts and no intention to violate regulations or make undue gains.
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,792.10
#1 4,29,984.82
40.68
#1 54,729.00
9.71
#1 10,980
2.89
65.19
6,372.50
1,69,169.85
69.05
9,712.00
18.67
2,191
35.10
45.82
3,734.10
1,26,378.91
58.80
11,539.40
6.99
1,911
30.46
53.76
1,505.50
1,21,607.38
22.73
28,409.50
7.12
5,291
3.71
45.79
1,280.20
1,06,847.25
#1 18.15
33,741.20
16.73
5,725
-0.38
62.83
2,073.90
94,726.32
21.34
22,909.50
13.74
3,306
#1 72.75
65.12
934.00
93,982.25
18.56
23,511.00
18.55
4,615
34.60
45.40
2,201.40
90,864.65
52.05
12,744.20
#1 20.90
2,007
-21.05
33.69
1,202.00
69,812.36
20.70
32,345.60
9.43
3,484
3.81
59.65
5,629.50
67,309.12
28.29
13,458.30
3.70
2,216
10.98
49.41
Growth Rate
Revenue Growth
47.21 %
Net Income Growth
45.25 %
Cash Flow Change
128.11 %
ROE
-500.68 %
ROCE
1,124.51 %
EBITDA Margin (Avg.)
-0.45 %

Quarterly Financial Results

Quarterly Financials
Jun 2024
Sept 2024
Jun 2025
Sept 2025
Revenue
317
299
353
413
Expenses
257
234
273
318
EBITDA
61
64
80
95
Operating Profit %
19 %
21 %
22 %
23 %
Depreciation
9
8
10
12
Interest
10
7
11
11
Profit Before Tax
41
49
60
72
Tax
16
15
16
18
Net Profit
26
35
43
54
EPS in ₹
1.66
2.27
2.81
3.49

Balance Sheet

Balance Sheet
2020
2021
2022
2023
2024
2025
Total Assets
430
538
560
750
1,110
1,451
Fixed Assets
157
188
193
199
307
286
Current Assets
265
340
328
502
763
1,063
Capital Work in Progress
2
6
3
25
10
7
Investments
19
14
0
0
0
522
Other Assets
252
331
364
526
793
0
Total Liabilities
430
538
560
750
1,110
1,451
Current Liabilities
78
111
184
361
573
786
Non Current Liabilities
12
53
71
102
152
124
Total Equity
341
374
305
286
385
541
Reserve & Surplus
335
369
300
281
370
526
Share Capital
5
5
5
5
15
15

Cash Flow

Cash Flow
2020
2021
2022
2023
2024
Net Cash Flow
1
67
-46
16
-4
Investing Activities
-84
-46
-46
-32
-68
Operating Activities
6
62
-63
-75
21
Financing Activities
80
52
63
123
44

Share Holding

% Holding
Jul 2024
Sept 2025
Oct 2025
Promoter
84.15 %
59.99 %
59.99 %
FIIs
0.00 %
9.37 %
9.37 %
DIIs
0.00 %
10.54 %
10.54 %
Government
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
18.28 %
18.28 %
Others
15.85 %
1.82 %
1.82 %
No of Share Holders
15
1,05,311
1,05,311

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
13 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Nov 2025 638.50 627.25

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Kotak Midcap Fund Direct-Growth
0.35%
3455273
0.35%
0.35%
Motilal Oswal Small Cap Fund Direct - Growth
2.38%
2345985
2.38%
2.38%
Kotak Manufacture in India Fund Direct - Growth
1.90%
833029
1.90%
1.90%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct - Growth
0.69%
721680
0.69%
0.69%
HDFC Innovation Fund Direct-Growth
1.11%
491670
1.11%
1.11%
Mirae Asset Healthcare Fund Direct - Growth
0.82%
372780
0.82%
0.82%
Canara Robeco Manufacturing Fund Direct - Growth
1.37%
372780
1.37%
1.37%
HDFC Pharma And Healthcare Fund Direct - Growth
1.00%
317220
1.00%
1.00%
ICICI Prudential Exports and Services Fund Direct-Growth
1.35%
309270
1.35%
1.35%
PGIM India Flexi Cap Fund Direct-Growth
0.28%
285000
0.28%
0.28%
Bajaj Finserv Balanced Advantage Fund Direct-Growth
1.28%
274597
1.28%
1.28%
HDFC Business Cycle Fund Direct - Growth
0.46%
222060
0.46%
0.46%
Edelweiss Recently Listed IPO Fund Direct-Growth
1.20%
187442
1.20%
1.20%
Bajaj Finserv Multi Asset Allocation Fund Direct-Growth
0.90%
186390
0.90%
0.90%
PGIM India Large and Mid Cap Fund Direct - Growth
1.21%
156660
1.21%
1.21%
Bajaj Finserv Healthcare Fund Direct-Growth
2.35%
127632
2.35%
2.35%
Kotak Healthcare Fund Direct - Growth
1.32%
103110
1.32%
1.32%
PGIM India ELSS Tax Saver Fund Direct-Growth
0.77%
96900
0.77%
0.77%
PGIM India Multi Cap Fund Direct-Growth
1.37%
96630
1.37%
1.37%
PGIM India Healthcare Fund Direct-Growth
3.87%
66960
3.87%
3.87%
PGIM India Retirement Fund Direct - Growth
1.28%
19980
1.28%
1.28%

Technical Indicators

RSI(14)
Neutral
45.70
ATR(14)
Less Volatile
29.31
STOCH(9,6)
Oversold
10.88
STOCH RSI(14)
Oversold
3.79
MACD(12,26)
Bearish
0.00
ADX(14)
Weak Trend
22.56
UO(9)
Bearish
33.65
ROC(12)
Downtrend And Accelerating
-10.70
WillR(14)
Oversold
-90.41